The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125828081 12582808 1 I 20131030 20131108 20160722 20160722 EXP US-BAXALTA-2013BAX045037 BAXALTA 61.34 YR M Y 104.00000 KG 20160721 OT US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125828081 12582808 1 PS RIXUBIS COAGULATION FACTOR IX RECOMBINANT HUMAN 1 Intravenous (not otherwise specified) 6122 UNITS +/- 10% DAILY X 4 Y TNA13006AC 125446 POWDER AND SOLVENT FOR SOLUTION FOR INJECTION QD
125828081 12582808 2 SS RIXUBIS COAGULATION FACTOR IX RECOMBINANT HUMAN 1 UNK Y TNA13007AB 125446 POWDER AND SOLVENT FOR SOLUTION FOR INJECTION
125828081 12582808 3 SS RIXUBIS COAGULATION FACTOR IX RECOMBINANT HUMAN 1 Intravenous (not otherwise specified) 6122 UNITS +/- 10% DAILY X 4 Y TNA13007AB 125446 POWDER AND SOLVENT FOR SOLUTION FOR INJECTION QD
125828081 12582808 4 SS LITHIUM CARBONATE. LITHIUM CARBONATE 1 Oral 300MILLIGRAM 2X A DAY Y 0 300 MG CAPSULE BID
125828081 12582808 5 C ATENOLOL. ATENOLOL 1 Oral 100MILLIGRAM1X A DAY 0 100 MG QD
125828081 12582808 6 C Bupropion HCL BUPROPION HYDROCHLORIDE 1 Oral 150MILLIGRAM2X A DAY 0 150 MG BID
125828081 12582808 7 C LEVOTHYROXINE. LEVOTHYROXINE 1 Oral 100MICROGRAM1X A DAY 0 100 UG QD
125828081 12582808 8 C PRILOSEC OMEPRAZOLE MAGNESIUM 1 Oral 1X A DAY 0 TABLET QD
125828081 12582808 9 C SIMVASTATIN. SIMVASTATIN 1 Oral 80MILLIGRAM1X A DAY 0 80 MG QD
125828081 12582808 10 C BUSPIRONE BUSPIRONE HYDROCHLORIDE 1 Oral 10MILLIGRAM2X A DAY 0 10 MG TABLET BID
125828081 12582808 11 C BUSPIRONE BUSPIRONE HYDROCHLORIDE 1 Oral 10MILLIGRAM1X A DAY 0 10 MG TABLET QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125828081 12582808 1 Factor IX deficiency
125828081 12582808 3 Factor IX deficiency
125828081 12582808 4 Product used for unknown indication
125828081 12582808 5 Product used for unknown indication
125828081 12582808 6 Product used for unknown indication
125828081 12582808 7 Product used for unknown indication
125828081 12582808 8 Product used for unknown indication
125828081 12582808 9 Product used for unknown indication
125828081 12582808 10 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
125828081 12582808 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
125828081 12582808 Acute kidney injury
125828081 12582808 Claustrophobia
125828081 12582808 Cognitive disorder
125828081 12582808 Dyspnoea
125828081 12582808 Feeling hot
125828081 12582808 Gait disturbance
125828081 12582808 Hypersensitivity
125828081 12582808 Neurological symptom
125828081 12582808 Pruritus
125828081 12582808 Toxicity to various agents
125828081 12582808 Tremor

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125828081 12582808 1 20131029 20131031 0
125828081 12582808 2 20131029 20131031 0
125828081 12582808 3 20131029 20131031 0
125828081 12582808 4 20131101 0